,
your personalized virtual assistant to find clinical trials. Go head, 
Liz Paul
Institute for Neurodegenerative DisordersNew haven, Connecticut - 06510 (203 401 4362) |
- CLINICAL TRIALS 2
- CONDITIONS5
- INTERVENTIONS2
- SINCE2009
Evaluation of [123I]MNI-420 and Single Photon Emission Computed Tomography (SPECT) as a Marker of the Adenosine A2a Receptor in Subjects With Parkinson Disease (PD) and Huntington Disease (HD)
July 2009 - July 2010
A PET Brain Imaging Study of mGluR5 in Subjects With PD HD FXS & ASD
March 2009 - March 2011
Parkinson Disease
Autistic Disorder
Child Development Disorders, Pervasive
Huntington Disease
Fragile X Syndrome
[123i]Mni-420
(18f)Fpeb
